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The bacterial species Clostridium botulinum is capable of producing botulinum 
toxin, arguably the most potent toxin known. Symptoms can occur with just one 
microgram of toxin per kilogram of body weight, which is 275 times more poisonous 
than cyanide (Van Rynen, Rega, Budd, & Burkholder-Allen, 2009). Found in soil, this 
ubiquitous species is a gram-positive, rod-shaped, spore-forming, obligate anaerobic 
bacterium.  The spores are heat resistant, killed only by exposing to high heat for 
several minutes (Josko, 2004). But, given the ideal environment the spores will 
germinate into toxin-producing bacteria. This toxin then causes botulism within its host, 
a rare but life-threatening illness presenting with symmetric, descending paralysis that 
can be fatal when it affects the body’s ventilitory function.  
Three forms of botulism poisoning were initially accepted until recent years when 
three more have been reported. They are differentiated by the means of acquisition: 
food-borne, infant (due to ingestion of spores via raw honey or dust), and wound. The 
additional types are adult intestinal (similar to infant botulism because toxin is produced 
within the gastrointestinal tract of an infected adult host), inadvertent injection-related, 
and inhalational botulism (of which there are 3 lab cases reported, and the form that 
would occur if aerosolized toxin was released in an act of bioterrorism) (Horowitz, 
2005). Bioterrorism is the use of biological agents (both infectious agents and the toxins 
they produce) to intimidate governments or societies on behalf of an ideological cause. 
It is estimated that one gram of aerosolized botulinum toxin could kill at least one million 
people (Arnon et al., 2001). 2 
C. botulinum toxin is too large to cross the blood-brain barrier and therefore it 
targets cells in the peripheral nervous system where acetylcholine acts to activate 
muscles. The toxin is a polypeptide made up of a heavy and a light chain joined 
together by a single disulfide bond.  The light chain, an endopeptidase, breaks down the 
protein complex required for the fusion of acetylcholine-containing vesicles at the nerve 
terminal. By blocking this step, the toxin irreversibly acts to prevent release of 
acetylcholine at the neuromuscular junction, thus inhibiting muscle contraction and 
causing paralysis.  Depending upon the amount of toxin absorbed into the blood, 
botulism may manifest mildly or rather severely, causing such paralysis that some 
patients may require months of ventilator support. It is important to recognize that 
botulism presents as symmetric, descending flaccid paralysis that always begins in the 
bulbar musculature as multiple cranial nerve palsies. Common symptoms are 
sometimes referred to as the “4 D’s”: diplopia, dysarthria, dsyphonia, and dysphagia. 
Additionally, botulism (except wound botulism) is an afebrile illness that does not 
decrease the patient’s mental status despite ensuing weakness and paralysis until later 
in the process when carbon dioxide narcosis occurs due to hypoventilation (Arnon et al., 
2001).  
Treatment includes close monitoring for respiratory failure, as this is the most 
common cause of death due to botulism poisoning. Supportive therapy may include 
mechanical ventilation, and nutritional support via tube feeding or hyperalimentation due 
to dysphagia and other complications. Other than supportive therapy, the only treatment 
available is antitoxin therapy. And if given early, will minimize further disruption of the 
release of acetylcholine in other nerves, but not reverse present paralysis from nerves 3 
already affected (Arnon et al., 2001). There are two types of medications available in 
the United States: antitoxin and an immune globulin. First is equine serum botulism 
antitoxin, which used to treat children over one year of age and adults. Secondly, there 
is human-derived botulinum immune globulin (BIG-IV or BabyBIG), which is used for 
infants less than one year of age. The antitoxin is a form of artificial acquired passive 
immunity (i.e. antibodies transferred from horse or human) that attaches and neutralizes 
circulating toxin that has not entered any cell or receptor site. Therapy available for 
infants less than one year of age is human-derived botulinum immune globulin (Baby-
BIG) (Horowitz, 2005). At any age, recovery occurs when the body sprouts new motor 
axon threads for reinnervation of paralyzed muscle fibers, which takes up to six months 
(Arnon et al., 2001).  According to Horowitz (2005), “Delay to administering the antitoxin 
is the most important factor that affects clinical course and outcome” (p. 836). Delay 
must be minimized by prompt identification of symptoms, which is essential for a 
favorable prognosis and effective treatment of botulism. Ultimately this all begins with 
awareness and knowledge. 
According to the Centers for Disease Control and Prevention (CDC), 
approximately 145 cases of botulism are reported yearly in the United States. The 
majority of cases are infant (65%), and less frequent is food-borne (15%), and wound 
botulism (20%). Seldom is adult enteric infection reported (U.S. Centers for Disease 
Control and Prevention, 2008).  
Due to its extreme potency, lethality, ease of production, and stability in 
environment, botulinum toxin is a major threat as a naturally occurring illness and a 
biological weapon (Shukla & Sharma, 2005). Thus, it is listed along with anthrax, 4 
plague, smallpox, tularemia, and viral hemorrhagic fevers as Category A agents on the 
CDCs list of organisms that pose the highest risk/highest priority to national security.  
Consider that botulinum toxin is the most poisonous substance known and is 275 times 
more poisonous than cyanide and 100,000 times more toxic than sarin (Van Rynen et 
al., 2008). 
According to Arnon et al. (2001), only the tiniest amount of toxin, 0.001 
micrograms per kilogram will cause symptoms in the human being.  Additionally the 
same researchers noted, “A single gram of crystalline toxin, evenly dispersed and 
inhaled, would kill more than 1 million people.  Even if practical details might make this 
type of dissemination difficult, it is a nonetheless an accurate statement.  While means 
of bioterrorism via inhalation of botulinum toxin has been studied, so has its ingestion 
via intentionally contaminated food. Specifically, a mathematical model was calculated 
by Wein and Liu in 2005 which predicted that 1 gram of the toxin in commercially-
distributed milk consumed by more than 550,000 urban dwellers would result in 100,000 
casualties. Consider 10 grams of toxin in the previous scenario and the casualties could 
rise to 500,000. Therefore, unlike a hypothetical smallpox epidemic, the threat of a 
mass casualty incident from botulism should be considered a definite and credible 
potential threat.  
With this unfortunate distinction, the effects of botulinum toxin should be well 
known by at least those in the health care community. Currently, it is unclear how 
knowledgeable students in the health care professions are about botulism. Great efforts 
should be taken to ensure that at a minimum, those entering into and practicing in 5 
healthcare are prepared to recognize and respond to this illness in the time necessary 
to avoid a fatal outcome.   6 
Chapter 2/Literature Review 
According to the CDC (2008), rates of food-borne and infant botulism have 
remained steady in recent years, while wound botulism has seen an increase due to 
black tar heroin use. In addition to C. botulinum causing these naturally occurring forms 
of disease, the CDC has placed this species among the most worrisome for their use as 
a bioweapon. Numerous studies demonstrate the seriousness of botulism regardless of 
its route to producing disease. Due to the number of people who could be sickened with 
so little toxin makes the threat of intentional release in an act of terrorism very 
concerning and very real.  
The interest in botulinum toxin as a biologic agent began at least 65 years ago.  
In fact, during the Japanese’s occupation in Manchuria in the 1930’s, their biological 
warfare group (Unit 731) fed cultures of C. botulinum to prisoners and produced lethal 
outcome. In addition, during WWII, several countries investigated the use of botulinum 
toxin as a biologic agent.  And, even after 1972, when the offensive research and 
production of biological weapons was prohibited by the Biological and Toxin Weapons 
Convention, Iraq and the Soviet Union still produced the toxin for use as a weapon 
(Arnon et al., 2001).  
Indeed, terrorists continued its use as demonstrated in the early 1990’s when the 
Japanese cult, Aum Shinrikyo released an ineffective C. botulinum aerosol preparation 
against a U.S. military facility (Horowitz, 2005). Additionally, United Nations inspections 
of Iraq after the first Gulf War, revealed approximately 19,000 liters of concentrated 
botulinum toxin were produced, more than any other biological agent. Approximately 
half of that was loaded into military weapons, but much remains unaccounted for (Arnon 7 
et al., 2001). Additionally, countries that have developed or are believed to be 
developing botulinum toxin for use as a weapon currently and are listed by the US 
government as “state sponsors of terrorism” include Iran, Iraq, North Korea, and Syria  
(Arnon et al., 2001).  While some researchers may question the potential for terrorist 
use of aerosol dissemination of botulinum toxin due to difficulty in stabilization and 
concentration, inhalational botulism has actually occurred in humans accidentally. 
Moreover, there is concern of deliberate contamination of the food or water supply.   
Of the bioterror attacks not involving genetic engineering, one of the possible 
scenarios that pose the greatest threat to humans is a release of botulinum toxin in cold 
drinks. For example, the milk supply has been studied as a potential bioterrorist target 
because of the multiple and rapid steps in transportation and processing, wide 
distribution, and for the fact that it is a highly consumed food. In 2005, Wein and Liu 
described a hypothetical bioterrorism scenario that analyzed the outcome if 1 gram of 
botulinum neurotoxin was released into a holding tank of approximately 50,000 gallons 
of raw milk. It was determined that if all of this milk was distributed and consumed 
without detection, there would be a mean of 100,000 casualties based on 68.4% 
inactivation of the toxin by heat treatment (170
0 F/77
0C for 15 min.). Of great importance 
is noting that early symptomatic detection in this model could avoid about 67% of the 
casualties.  
In response to this mathematical model, Weingart and Schreiber et al., (2010) 
analyzed milk contamination with botulinum toxin via a laboratory-scale pasteurization 
process. They used heat treatment commonly used by the dairy industry called high-
temperature short-time (HTST) pasteurization similar to industry standards (161
0F/72
0C 8 
for 15 sec.), and showed it would inactivate at least 99.5% of botulinum toxin in their 
milk samples. But, researchers also admit that “other complex food matrices or slight 
changes to the heating parameters might have a different effect on the stability of 
BoNT” (botulinum neurotoxin).  
The possibility of contamination of water supplies is an additional threat, as 
botulinum toxin has been shown to retain up to 50% of its activity for 5 to 70 days in 
various types of untreated water and beverages. There are many barriers to be noted 
such as dilution, and inactivation from chlorine, other disinfectants, hydrolysis, sunlight, 
microbes, and filtration to make this contamination less likely. But, personal-use water 
purification devices without reverse osmosis fail to remove the toxin. Most bottled water 
in the United States does utilize the process of reverse osmosis, but not all international 
bottled water sources do. Still, toxin introduction to municipal water supplies or to 
bottled water or other beverages is a threat that should be considered (Villar, Elliott, 
Davenport, & Davenport, 2006).  
With the reality that this toxin can cause disease via intentional use or otherwise, 
the health care community must be able to clinically recognize its symptoms and 
diagnose it efficiently.  Indeed, in the United States, the detection of such events is 
based on clinician reporting to the Centers for Disease Control and Prevention in order 
to maintain their well-established surveillance system. 
To illustrate the importance of the clinician’s ability to recognize botulism 
poisoning, the following is a discussion of a case that went undetected for a prolonged 
period of time.  In Vancouver between July and September of 1985 one bottle of garlic 
intermittently used in a restaurant caused a botulism outbreak affecting 36 people over 9 
2 distinct clusters of illnesses separated by about a month.  “More than 2 months after 
the beginning of the outbreak and several days after the last patient ate at the 
restaurant, botulism was first diagnosed”, even when the median incubation period from 
ingestion to neurologic symptoms was only 2.3 days and the median period from 
ingestion to hospitalization was 7 days (St. Louis et al., 1988). In this outbreak, the 
patients did present with typical symptoms of botulism poisoning including muscle 
weakness (100%), dysphagia (91%), blurred vision (88%), dry mouth (85%), dysphonia 
(82%), dizziness (73%), and diplopia (67%).  Most patients were hospitalized, some 
required mechanical ventilation, and there was no mortality associated with this 
outbreak. The most common working diagnoses in these patients before correct 
identification of botulism was: myasthenia gravis, stroke, the atypical or descending 
variant of Guillain-Barre syndrome, psychiatric disorders and viral syndromes.  
Since the events in September 2001, studies have been done to assess 
physician preparedness for bioterrorism. One national survey of hundreds of randomly 
selected family physicians, revealed that about 75% of them “did not feel prepared to 
respond to a bioterrorist attack” (Chen, Hickner, Fink, Galliher, & Burstin, 2001). And, 
only 24% of those surveyed thought they “could recognize signs and symptoms of an 
illness in their patients due to bioterrorism” and 38% rated their current knowledge of 
the diagnosis and management of bioterrorism related illness as “poor”. Lastly, in this 
study, only 18% of physicians reported previous training in bioterrorism preparedness. 
A similar study in 2003 was conducted, but compared the preparedness of 
emergency and primary care physicians via a random sample, national survey. More 
emergency physicians reported that they were “well prepared to play a role in 10 
responding to possible bioterror attack” than primary care physicians (43% vs. 21%) 
(Alexander, Larkin, & Wynia, 2006). 
  Another study in 2005 assessed the ability of physicians to diagnose and 
manage illness caused by four of the category A bioterrorism agents (smallpox, anthrax, 
botulism, and plague). Six hundred thirty one internal medicine physicians (including 
residents and some attending physicians) were included in the research which showed 
49.6% were able to correctly diagnose botulism poisoning on the pretest and about 
90%, after the didactic education, on the post test. Results of the study “demonstrated 
that physicians are undertrained in the diagnosis and management of infection caused 
by 4 pathogens identified as likely to be used in a potential bioterrorism attack” 
(Cosgrove, Perl, Song, & Sisson, 2005).  
Since the 2001 terrorist attack with anthrax, research regarding botulism 
poisoning has shifted from various cases of food borne ingestion, to the threat of its use 
as a weapon and our preparedness to recognize such an event. With botulinum toxin as 
one of the top agents feared for use in such an attack, it places healthcare providers at 
the forefront in its initial detection. Therefore, with this group holding responsibility to 
recognize and report botulism,  it’s worth not only asking them how ready they feel to 
take on such a task, but to actually determine how much they know on the subject. In 
addition, most studies focus their attention on physicians’ ability to diagnose botulism 
poisoning, but in reality, health care is a multidisciplinary team effort that involves 
nurses in triage to any and all type of clinical provider. Today there are physician 
assistants and nurse practitioners also work in emergency departments and urgent care 
centers, diagnosing and treating patients.  And some patients may present at their 11 
pharmacy and question the pharmacist on which over the counter medication may help 
their symptoms instead of, or before presenting in to an emergency department.  
Essentially, potential providers in the healthcare system have expanded over the 
years and so too, this study attempts to analyze the knowledge of botulism in such a 
group as a means to identify preparedness to handle this disease whether it is of natural 



















A survey questionnaire was developed for use as a tool to assess the current 
knowledge of botulism in health care students. The study was reviewed and approved 
by the UTHSC Institutional Review Board.  
The sample for the study included students of the UTHSC in the progressions of 
nursing, pharmacology and physician assistant studies, who were required to complete 
the AMA BDLS training course. The survey questionnaire and a cover letter were 
included in the packets for the BDLS course. Participants were asked to read the cover 
letter, which stated that participation was voluntary and anonymity would be ensured.  
Participants were asked to complete a pretest before the training course which 
they subsequently turned into a collection box during the break. The training course was 
conducted, which included content on botulism poisoning and upon conclusion, the 
participants were asked to complete and return the post test. A number was included on 
these pre and post test questionnaires for the purpose of matching them pre course and 
post course, while still maintaining anonymity. All of the completed surveys were kept in 
a locked office until coded and entered into a Statistical Package for the Social 
Sciences (SPSS)
1 data file for analysis. 
  This survey was used to assess the current knowledge of botulism in healthcare 
students, and included demographic items and questions about botulism. The first 
questions on the survey asked the participants which profession they are studying and if 
they have had classes on infectious diseases. The next eleven questions addressed 
knowledge of botulism in regard to its diagnosis and treatment. The survey instructed 
participants not to guess if unsure of an answer.  13 
                                                                                                                                             
1 SPSS Corp, Chicago, IL 14 
Chapter 4/Results 
A total of 301 pre-tests were completed and received for analysis. Demographic 
results showed that 108 (36%) participants were nursing students, 156 (52%) were 
pharmacy students and 37 (12%) were physician assistant students (Table 1). Ninety 
three percent of students reported they had had classes on infectious diseases during 
the course of their studies. Consider the statistical hypotheses for this study, which are 
as follows: 
 Ho: There will be no statistically significant differences in the pretest scores 
among the student groups ( = 0.05).  
Ho2: None of the student groups will achieve a mean score of 60% or greater on 
the pretest ( = 0.05).  
Ho3: There will be no statistically significant differences among the posttest 
scores among the student groups. 
Ho4:  There will be no statistically significant difference in the pretest versus 
posttest score for nursing students. 
Ho5: There will be no statistically significant difference in the pretest versus 
posttest score for pharmacy students. 
Ho6: There will be no statistically significant difference in the pretest versus 
posttest score for physician assistant students. 
After analyzing the results, the mean percentage of correct answers over all 
groups on the pre-test was very poor, 25.55% (sd ± 19.40%, n=301). Specific group 
pre-test results are as follows: nursing students scored 17.33% (sd ± 15.14%, n=108), 
pharmacy students 25.23% (sd 17.26%, n=156), and physician assistant students 15 
50.86% (sd 17.60%, n=37) (Table 2).  A 95% confidence interval was used to show that 
the lower and upper boundaries for the means are the following: overall (23.5 – 27.7), 
nursing students (14.4 - 20.2), pharmacy students (22.5 – 27.9), physician assistant 
students (44.9 – 56.7).  
Although none of the professions achieved a passing mean score of 60% there 
were significant differences among the professions. Analysis of variance indicated there 
were significant differences among the professions (F2,298 = 56.388, p < 0.001). 
Levene’s test for equality of variance indicated variances were equal (F2,298 = 1.938, p = 
ns) and a Tukey HSD was used for post hoc tests. Because the group sizes were 
unequal the harmonic mean was used for comparisons. Table 3 indicates the mean 
score for the pretest for each of the professions were significantly different from the 
others. 
Following the BDLS course the students were retested on their knowledge of 
botulism. The post-test showed improvement from the pre-test in all three groups of 
health care students. The mean post-test score for all students was 73.3% (sd 
±15.32%, n=149). There were a total of 149 post-tests returned representing 52 nursing 
students, 78 pharmacy students, and 19 physician assistant students.  The means for 
percentage of questions answered correctly are as follows: 72.30% (sd ± 15.32%, 
n=149) overall, and among groups of students 68.88% (sd ± 16.23%, n=52) for nursing 
students, 73.89% (sd ± 14.08%, n=78) for pharmacy students, and 75.11% (sd ± 16.82) 
for physician assistant students (Table 4).  
All of the professions achieved a passing mean score of 60% or greater, and 
there were no significant differences among the professions. Analysis of variance 16 
indicated there were no significant differences among the professions (F2,146 = 2.066, p 
= ns). When the pre-test and post-test mean score were compared, paired t tests 
revealed a significant increase in the mean score for each the three professions.  For 
the nursing students, the pre-test mean was 18.00 (sd ±15.53, n=52,) while the post-test 
mean was increased to 68.88 (sd ±16.23, n=52) and t51 =16.736, p<0.001. The 
pharmacy students pre-test mean was 25.28 (sd±17.06, n=78) and for the post-test the 
mean raised to 73.89 (sd ±14.08, n=78) and t77 =22.095, p<0.001.  Lastly, the physician 
assistant students pre-test mean was 47.84 (sd ±19.36, n=19) and post-test mean of 
75.11 (sd ±16.82, n=19) and t18 =6.829, p<0.001.          
 
 
  17 
Chapter 5/Discussion 
The results of this study plainly show that students in health care do not have 
adequate knowledge regarding botulism. This is evidenced by the fact that the overall 
mean on a pre-test with 11 questions on botulism was 25.5% correct answers. While 
none of the three groups of students had a mean with a passing score (60% or greater), 
the physician assistant students answered the most questions correctly, followed by 
pharmacy students and lastly, nursing. This is likely a reflection of curriculum content 
differences related to infectious disease among the areas the students were studying. 
The post-test clearly shows the improvement of knowledge base after teaching 
on botulism was included in the BDLS course. The overall mean on the post-test was 
71.8% correct answers, which is a passing score and shows over 45% improvement. 
For each group of students, the post-test mean was improved and all were passing 
percentages.   
Furthermore, the hypotheses presented earlier in the study can now be 
assessed: 
Ho: There will be no statistically significant differences in the pretest scores 
among the student groups ( = 0.05) - rejected.  
Ho2: None of the student groups will achieve a mean score of 60% or greater on 
the pretest ( = 0.05) – fail to reject.  
Ho3: There will be no statistically significant differences among the posttest 
scores among the student groups – fail to reject. 
Ho4:  There will be no statistically significant difference in the pretest versus 
posttest score for nursing students - rejected. 18 
Ho5: There will be no statistically significant difference in the pretest versus 
posttest score for pharmacy students - rejected. 
Ho6: There will be no statistically significant difference in the pretest versus 
posttest score for physician assistant students - rejected. 
While the study included just over 300 students, there were some limitations in 
the fact that the sample analyzed was taken from one Midwestern university. This may 
make it harder to generalize our results across the country and among healthcare 
students studying at other universities, but it is consistent with the lack of knowledge of 
botulism seen in health care professionals as cited previously.  
Less than half of the students who completed the pretest completed the posttest. 
This decreases the number of subjects available to analyze in our posttest sample. In 
addition, posttest knowledge was acquired immediately after the BDLS course was 
completed, and thus it is uncertain how much information on botulism was retained.  
This study also did not utilize a true control group. Even with these limitations, 
there was no other reason for such improvement in test scores than the education on 
botulism that participants received during the course.  19 
Conclusion 
Clostridium botulinum and the toxin it produces have been extensively studied 
and its effects well documented since first investigated in the 1820’s. Yet it is often 
misdiagnosed when it occurs from natural or accidental causes, and it is questionable at 
what cost it would be recognized if used intentionally. Despite the facts that have been 
so carefully laid out about botulinum toxin and potential for misuse by terrorists, it is not 
well know by students in health care professions.  
Like any other infectious disease or category A agent, education on botulism 
poisoning must be included in the curriculum of health care students.  Whether it is 
included as part of a program didactic requirement or via a BDLS training course 
required by the institution, as it was for the UTHSC students, it must be taught. Those in 
health care professions can only respond efficiently and effectively to this disease if 
there is education and preparedness. 
It cannot be acceptable that a toxin as potent as botulinum that discriminates 
against no age, race, or gender, is found naturally across the world, has been produced 
and released by terrorists, has no cure, and requires early detection to save the victim’s 
life, could be so unknown to students in health care professions.   
Recommendations for further research on this topic are to use a larger sample 
size which includes health care students from around the country and to utilize a Quasi-
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Nursing 108  36% 




Total 301  
 
 




Number Mean  Standard 
Deviation 
Nursing 108  17.3394 15.14746 
Pharmacy 156  25.2322  17.26625 
Physician Assistant 37  50.8602  17.60014 
Total 301  25.5505  19.40019 
 
 





studying?  N 
Subset for alpha = 0.05 
1  2  3 
Nursing    108  17.3394    
Pharmacy  156    25.2322  
Physician 
Assistant 
37      50.8602
Sig.    1.000 1.000 1.000
Means for groups in homogeneous subsets are 
displayed. 











Number Mean  Deviation 
Standard 
Nursing 52  68.8811 16.23700 
Pharmacy 78  73.8928  14.08045 
Physician Assistant 19  75.1196  16.82899 








Mean Number  Standard 
Deviation 
Pre-test  18.0056  52 15.53720 
Post-test  68.8811  52 16.23700 




 Mean  Number  Standard 
Deviation 
Pre-test  25.2895  78 17.06355 
Post-test  73.8928  78 14.08045 
    t77 =22.095, p<0.001 
 
 
Physician Assistant students 
 Mean  Number  Standard 
Deviation 
Pre-test  47.8474  19 19.36782 
Post-test  75.1196  19 16.82899 
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Paul P. Rega, MD, FACEP 
Department of Public Health and Homeland Security 
Health Science Campus 
Glendale Medical Building 
3355 Glendale Avenue 





Botulism is a condition that occurs regularly across this nation and the world.  Although botulism 
typically involves, at most, a handful of cases, it must be recognized as a potential weapon for 
terrorists. Therefore we feel it is our responsibility to prepare professionals to recognize and treat 
botulism. Regretfully little is known about what practicing clinicians (and students who are 
preparing to become clinicians) know about botulism.  The purpose of this letter and included 
questionnaire is to enlist your help in assisting us to assess your knowledge about botulism. The 
results will help provide information to develop education. 
 
The accompanying questionnaire consists of two sections: demographic information and 
knowledge of botulism (including signs, symptoms and treatment). The questionnaire should 
take less than ten minutes to complete.  Please answer the questions to the best of your ability, 
but if you are uncertain of the correct answer, please do not guess.  Participation in this study is 
completely voluntary, and you have the right to discontinue the survey at any time and to leave 
any questions blank.   
 
All returned questionnaires will be compiled and will have no specific identifiers for you.  This 
is to maintain your anonymity.  There will be no monetary or gift compensation for your 
participation in this study, but your participation is greatly appreciated. 
 
If you should have any questions, please feel free to contact, Dr. Christopher Bork at 419-383-
6301 or Dr. Paul P. Rega at 419-383-6722.  We can also be reached via e-mail at 
Christopher.Bork@utoledo.edu or Paul.Rega@utoledo.edu.     
 





Christopher E. Bork, Ph.D., P.T., EMT-B    Paul P. Rega, MD, FACEP 
College  of  Medicine      College  of  Medicine 
The University of Toledo        The University of Toledo 25 
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Demographic  Information       IRB  Approval  #106390 
 
1.  What is your professional background? 
 Nurse   Physician     Physician Assistant   EMT   
 Paramedic (EMT-P)   Other ______________________ 
 Student (please skip to question 5) 
 
2.  What is your specialty/area of practice? ________________________ 
 
3.  How many years have you worked in your profession? _______________  
 
4.  Are you currently practicing your profession?    Yes  No 
 




 Physician Assistant 
 Other ______________________________________ 
 
6.  Students: Have you had classes on infectious diseases?    Yes  No 
 
The next eleven (11) items address knowledge about botulism and its diagnosis and 
treatment. Please do not guess if you are unsure of an answer.  
 
7.  The appropriate personal protective equipment to wear when caring for a patient with 
suspected botulism includes 
a.  A surgical mask within three feet of the patient. 
b.  An N-95 respirator within three feet of the patient. 
c.  Does not require any respiratory protection. 
d.  Don’t know 
 
8.  Botulism, in its early stages, principally affects what system? 
a.  Cardiovascular 
b.  Immunological 
c.  Neurological 
d.  Don’t know 
 
9.  Common forms of botulism include food-borne, infant, and  
a.  Wound. 
b.  Naso-pharyngeal 
c.  Bubonic 26 
d.  Don’t know 
 
10. Baby-BIG (Botulism Immune Globulin) IV is medication reserved for babies with infant 
botulism up to the age of  
a.  Six months. 
b.  One year. 
c.  Five years. 
d.  Don’t know 
Please complete the items on the next side 
 
11. One of the earliest signs of infant botulism is 
a.  Fever 
b.  Cough 
c.  Constipation 
d.  Don’t know 
 
12. Which poison is more toxic than botulinum toxin? 
a.  Cyanide 
b.  Sarin 
c.  Neither 
d.  Don’t know 
 
13. One of the keys to the diagnosis of botulism is 
a.  A widened mediastinum on a chest x-ray. 
b.  Swollen lymph nodes in the groin and axillae. 
c.  Neither 
d.  Don’t know 
 
13. In the Centers for Disease Control and Prevention (CDC) categories of biological 
weapons of mass destruction, botulism resides in 
a.  Category A 
b.  Category B 
c.  Category C 
d.  Don’t know 
 
14. If botulism antitoxin is administered within one or two days of the onset of disease, 
symptoms will typically resolve in 
a.  Less than 48 hours. 
b.  Less than one week. 
c.  Neither. 
d.  Don’t know 
 
15. One manifestation typically found in a patient with botulism is 
a.  Ptosis 
b.  Pruritus 
c.  Pancytopenia 27 
d.  Don’t know 
 
16. A syndrome that is typically seen early with food-borne botulism is 
a.  Altered sensorium. 
b.  Nausea, vomiting and diarrhea. 
c.  Paresthesia 
d.  Don’t know 
 
 
Thank you for participating in this survey.  28 
Abstract 
Objective: To assess the current knowledge of botulism in health care students. 
Methods: A pre-test survey on botulism was given to students in the progressions of 
nursing, pharmacology and physician assistant studies at the University of Toledo 
Health Science Campus, before they began an AMA Basic Disaster Life Support 
(BDLS) training course. After the course, which included information on botulism, the 
students completed a post-test survey. 
Results: A total of 301 pre-test surveys were collected with a mean of 25% correct. 
Ninety three percent reported having had classes on infectious diseases. After the 
BDLS course with teaching on botulism, the post-test scores were significantly improved 
among all student groups with a mean score of 72%.  
Conclusions: Students in health care have inadequate knowledge of botulism and 
there are statistically significant differences between groups of students based on area 
of study. Additionally, BDLS serves as a reasonable platform for botulism education. 
  
 
 